Celiac disease, wheat allergy, and nonceliac sensitivity to gluten: topical issues of the pathogenesis and diagnosis of gluten-associated diseases
- 作者: Kaminarskaya Y.1
-
隶属关系:
- Chaika Healht
- 期: 卷 2, 编号 3 (2021)
- 页面: 113-124
- 栏目: Reviews
- URL: https://journals.rcsi.science/2658-4433/article/view/90770
- DOI: https://doi.org/10.17816/clinutr90770
- ID: 90770
如何引用文章
详细
Historically, wheat and other gluten-containing grains have been an essential part of the diet of many people worldwide. However, the widespread use of gluten-containing products has led to an increased incidence of adverse reactions associated with their consumption, such as celiac disease and wheat allergy, as well as nonceliac gluten sensitivity, which has become common in recent years.
Gluten-associated diseases have similar clinical manifestations (abdominal pain, bloating, diarrhea, nausea, and vomiting). The pathogenetic mechanisms underlying celiac disease and wheat allergy are quite well understood; in both cases, an immune response occurs when wheat proteins are consumed, both with effective treatment. Nonceliac gluten sensitivity is the subject of discussion; however, the processes underlying this disease are not fully understood; thus, its diagnosis and treatment have no unified approach. To date, nonceliac gluten sensitivity is a diagnosis of exclusion, which is established in the absence of markers of celiac disease or wheat allergy and improved following a gluten-free diet.
A gluten-free diet is the most effective treatment for gluten-related diseases. However, like any other strict dietary restriction, gluten avoidance can result in reduced intakes of important nutrients, such as dietary fiber, protein, and micronutrients. In recent years, an increasing trend is found in the general population without confirmed gluten-related disorders that gluten-free product consumption or gluten-free diet adherence since gluten avoidance can improve well-being or gluten can be toxic for all human beings
According to current guidelines, only patients diagnosed with celiac disease or wheat allergy are advised to follow a strict gluten-free diet.
Herein, the modern conception of the immunopathology of gluten-related diseases and an overview of new potential therapies are presented.
作者简介
Yuliya Kaminarskaya
Chaika Healht
编辑信件的主要联系方式.
Email: osipovaulia@gmail.com
ORCID iD: 0000-0002-9893-3292
SPIN 代码: 1333-6058
MD
俄罗斯联邦, 49-2, Bolshaya Academicheskaya street, Moscow, 125008参考
- Lebwohl B, Sanders DS, Green PH. Coeliac disease. Lancet. 2018;391(10115):70–81. doi: 10.1016/S0140-6736(17)31796-8
- Rai S, Kaur A, Chopra CS. Gluten-Free products for celiac susceptible people. Front Nutr. 2018;5:116. doi: 10.3389/fnut.2018.00116
- Reilly NR. The gluten-free diet: recognizing fact, fiction, and fad. J Pediatr. 2016;175:206–10. doi: 10.1016/j.jpeds.2016.04.014
- Cabrera-Chávez F, Dezar GV, Islas-Zamorano AP, et al. Prevalence of self-reported gluten sensitivity and adherence to a gluten-free diet in argentinian adult population. Nutrients. 2017;9(1):81. doi: 10.3390/nu9010081
- Ontiveros N, Rodríguez-Bellegarrigue CI, Galicia-Rodríguez G, et al. Prevalence of self-reported gluten-related disorders and adherence to a gluten-free diet in salvadoran adult population. Int J Environ Res Public Health. 2018;15(4):786. doi: 10.3390/ijerph15040786
- Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42(8):587–595. doi: 10.3109/07853890.2010.505931
- Borovik TE, Zakharova IN, Potapov AS, et al. Federal clinical guidelines for the provision of medical care to children with celiac disease. Moscow; 2015. 22 р. (In Russ).
- Guo CC, Huang WH, Zhang N, et al. Association between IL2/IL21 and SH2B3 polymorphisms and risk of celiac disease: a meta-analysis. Genet Mol Res. 2015;14(4):13221–13235. doi: 10.4238/2015.October.26.19
- Wacklin P, Kaukinen K, Tuovinen E, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis. 2013; 19(5):934–941. doi: 10.1097/MIB.0b013e31828029a9
- Brown JJ, Jabri B, Dermody TS. A viral trigger for celiac disease. PLoS Pathog. 2018;14(9):e1007181. doi: 10.1371/journal.ppat.1007181
- Tye-Din JA, Stewart JA, Dromey JA, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med. 2010;2(41):41ra51. doi: 10.1126/scitranslmed.3001012
- Camarca A, Anderson RP, Mamone G, et al. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol. 2009; 182(7):4158–4166. doi: 10.4049/jimmunol.0803181
- Hausch F, Shan L, Santiago NA, et al. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 2002;283(4):G996–1003. doi: 10.1152/ajpgi.00136.2002
- Ribeiro M, Rodriguez-Quijano M, Nunes FM, et al. New insights into wheat toxicity: Breeding did not seem to contribute to a prevalence of potential celiac disease’s immunostimulatory epitopes. Food Chem. 2016;213:8–18. doi: 10.1016/j.foodchem.2016.06.043
- Risnes LF, Christophersen A, Dahal-Koirala S, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128(6):2642–2650. doi: 10.1172/JCI98819
- Kooy-Winkelaar YM, Bouwer D, Janssen GM, et al. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proc Natl Acad Sci USA. 2017;114(6):E980–989. doi: 10.1073/pnas.1620036114
- Cook L, Munier CM, Seddiki N, et al. Circulating gluten-specific FOXP3(+)CD39(+) regulatory T cells have impaired suppressive function in patients with celiac disease. J Allergy Clin Immunol. 2017; 140(6):1592–1603.e8. doi: 10.1016/j.jaci.2017.02.015
- Di Sabatino A, Vanoli A, Giuffrida P, et al. The function of tissue transglutaminase in celiac disease. Autoimmun Rev. 2012; 11(10):746–753. doi: 10.1016/j.autrev.2012.01.007
- Sollid LM, Molberg O, McAdam S, Lundin KE. Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association? Gut. 1997;41(6):851–852. doi: 10.1136/gut.41.6.851
- Di Niro R, Mesin L, Zheng NY, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med. 2012;18(3):441–445. doi: 10.1038/nm.2656
- Caputo I, Lepretti M, Secondo A, et al. Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis. Amino Acids. 2013;44(1):251–260. doi: 10.1007/s00726-011-1120-y
- Alessio MG, Tonutti E, Brusca I, et al. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr. 2012;55(1):44–49. doi: 10.1097/MPG.0b013e3182470249
- Verma AK, Gatti S, Lionetti E, et al. Comparison of diagnostic performance of the IgA anti-tTG test vs IgA anti-native gliadin antibodies test in detection of celiac disease in the general population. Clin Gastroenterol Hepatol. 2018;16(12):1997–1998. doi: 10.1016/j.cgh.2018.03.028
- Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr. 2014;168(3):272–278. doi: 10.1001/jamapediatrics.2013.3858
- Repo M, Lindfors K, Mäki M, et al. Anemia and iron deficiency in children with potential celiac disease. J Pediatr Gastroenterol Nutr. 2017;64(1):56–62. doi: 10.1097/MPG.0000000000001234
- Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017; 49(1):23–31. doi: 10.1080/07853890.2016.1222450
- Zanchetta MB, Longobardi V, Bai JC. Bone and celiac disease. Curr Osteoporos Rep. 2016;14:43–48. doi: 10.1007/s11914-016-0304-5
- Jackson JR, Eaton WW, Cascella NG, et al. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q. 2012;83(1):91–102. doi: 10.1007/s11126-011-9186-y
- Hadjivassiliou M, Croall ID, Zis P, et al. Neurologic deficits in patients with newly diagnosed celiac disease are frequent and linked with autoimmunity to transglutaminase 6. Clin Gastroenterol Hepatol. 2019;17(13):2678–2686.e2. doi: 10.1016/j.cgh.2019.03.014
- Craig ME, Prinz N, Boyle CT, et al. Prevalence of celiac disease in 52,721 youth with type 1 diabetes: international comparison across three continents. Diabetes Care. 2017;40(8):1034–1040. doi: 10.2337/dc16-2508
- Parfenov AI, Bykova SV, Sabelnikova EA, et al. All-Russian consensus on diagnosis and treatment of celiac disease in children and adults. Ter Arkh. 2017;89(3):94–107. doi: 10.17116/terarkh201789394-107
- Leffler DA, Kelly CP, Green PH, et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015;148(7): 1311–1319.e6. doi: 1053/j.gastro.2015.02.008
- Lähdeaho ML, Kaukinen K, Laurila K, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014;146(7):1649–1658. doi: 10.1053/j.gastro.2014.02.031
- Goel G, King T, Daveson AJ, et al. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol Hepatol. 2017;2(7):479–493. doi: 10.1016/S2468-1253(17)30110-3
- Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol Rep. 2015;3(1):3–11. doi: 10.1093/gastro/gou065
- Pourpak Z, Mesdaghi M, Mansouri M, et al. Which cereal is a suitable substitute for wheat in children with wheat allergy? Pediatr Allergy Immunol. 2005;16(3):262–266. doi: 10.1111/j.1399-3038.2005.00263.x
- Keet CA, Matsui EC, Dhillon G, et al. The natural history of wheat allergy. Ann Allergy Asthma Immunol. 2009;102(5):410–415. doi: 10.1016/S1081-1206(10)60513-3
- Nilsson N, Nilsson C, Ekoff H, et al. Grass-Allergic children frequently show asymptomatic low-level ige co-sensitization and cross-reactivity to wheat. Int Arch Allergy Immunol. 2018;177(2): 135–144. doi: 10.1159/000489610
- Christensen MJ, Eller E, Mortz CG, et al. Wheat-dependent cofactor-augmented anaphylaxis: a prospective study of exercise, aspirin, and alcohol efficacy as cofactors. J Allergy Clin Immunol Pract. 2019;7(1):114–121. doi: 10.1016/j.jaip.2018.06.018
- Quirce S, Diaz-Perales A. Diagnosis and management of grain-induced asthma. Allergy Asthma Immunol Res. 2013;5(6):348–356. doi: 10.4168/aair.2013.5.6.348
- Brant A. Baker’s asthma. Curr Opin Allergy Clin Immunol. 2007;7(2):152–155. doi: 10.1097/ACI.0b013e328042ba77
- Armentia A, Díaz-Perales A, Castrodeza J, et al. Why can patients with baker’s asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant? Allergol Immunopathol (Madr). 2009;37(4):203–204. doi: 10.1016/j.aller.2009.05.001
- Sicherer SH, Sampson HA. Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141(1):41–58. doi: 10.1016/j.jaci.2017.11.003
- Scherf KA, Brockow K, Biedermann T, et al. Wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy. 2016;46(1):10–20. doi: 10.1111/cea.12640
- Cianferoni A. Wheat allergy: diagnosis and management. J Asthma Allergy. 2016;9:13–25. doi: 10.2147/JAA.S81550
- Sato S, Utsunomiya T, Imai T, et al. Wheat oral immunotherapy for wheat-induced anaphylaxis. J Allergy Clin Immunol. 2015; 136(4):1131–1133.e7. doi: 10.1016/j.jaci.2015.07.019
- Rodríguez del Río P, Díaz-Perales A, Sanchez-García S, et al. Oral immunotherapy in children with IgE-mediated wheat allergy: outcome and molecular changes. J Investig Allergol Clin Immunol. 2014;24(4):240–248.
- Khayatzadeh A, Gharaghozlou M, Ebisawa M, et al. A safe and effective method for wheat oral immunotherapy. Iran J Allergy Asthma Immunol. 2016;15(6):525–535.
- Reese I, Schäfer C, Kleine-Tebbe J, et al. Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI). Allergo J Int. 2018;27(5):147–151. doi: 10.1007/s40629-018-0070-2
- Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13. doi: 10.1186/1741-7015-10-13
- Talley NJ, Walker MM. Celiac disease and nonceliac gluten or wheat sensitivity: the risks and benefits of diagnosis. JAMA Intern Med. 2017;177:615–616. doi: 10.1001/jamainternmed.2017.0695
- Zevallos VF, Raker V, Tenzer S, et al. Nutritional wheat amylase-trypsin inhibitors promote intestinal inflammation via activation of myeloid cells. Gastroenterology. 2017;152(5):1100–1113.e12. doi: 10.1053/j.gastro.2016.12.006
- Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145(2):320–323. doi: 10.1053/j.gastro.2013.04.051
- El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J. 2015;14:92. doi: 10.1186/s12937-015-0080-6
- Catassi C, Elli L, Bonaz B, et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): the salerno experts’ criteria. Nutrients. 2015;7(6):4966–4977. doi: 10.3390/nu7064966
- Francisco CC, Gerardo SF, Noé O. the indistinguishable gluten vehicle and placebo in the diagnosis of NCGS. Am J Gastroenterol. 2018;113(10):1559–1560. doi: 10.1038/s41395-018-0127-3
- Figueroa-Salcido OG, Ontiveros N, Cabrera-Chavez F. Gluten vehicle and placebo for non-celiac gluten sensitivity assessment. Medicina (Kaunas). 2019;55(5):117. doi: 10.3390/medicina55050117
- Junker Y, Zeissig S, Kim SJ, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med. 2012;209(13):2395–2408. doi: 10.1084/jem.20102660
- Herrera MG, Pizzuto M, Lonez C, et al. Large supramolecular structures of 33-mer gliadin peptide activate toll-like receptors in macrophages. Nanomedicine. 2018;14(4):1417–1427. doi: 10.1016/j.nano.2018.04.014
- Leonard MM, Sapone A, Catassi C, Fasano A. Celiac disease and nonceliac gluten sensitivity: a review. JAMA. 2017;318(7):647–656. doi: 10.1001/jama.2017.9730
- Roncoroni L, Bascuñán KA, Vecchi M, et al. Exposure to different amounts of dietary gluten in patients with non-celiac gluten sensitivity (NCGS): an exploratory study. Nutrients. 2019;11(1):136. doi: 10.3390/nu11010136
- Dieterich W, Schuppan D, Schink M, et al. Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity. Clin Nutr. 2019;38(2):697–707. doi: 10.1016/j.clnu.2018.03.017
- Molberg O, Uhlen AK, Jensen T, et al. Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology. 2005;128(2):393–401. doi: 10.1053/j.gastro.2004.11.003
- Zanini B, Villanacci V, De Leo L, Lanzini A. Triticum monococcum in patients with celiac disease: a phase II open study on safety of prolonged daily administration. Eur J Nutr. 2015;54(6):1027–1029. doi: 10.1007/s00394-015-0892-3
- Niland B, Cash BD. Health benefits and adverse effects of a gluten-free diet in non-celiac disease patients. Gastroenterol Hepatol (NY). 2018;14(2):82–91.
- Wu JH, Neal B, Trevena H, et al. Are gluten-free foods healthier than non-gluten-free foods? An evaluation of supermarket products in Australia. Br J Nutr. 2015;114(3):448–454. doi: 10.1017/S0007114515002056